SAT-059 Treatment Of Primary Aldosteronism With The mTORC1 Inhibitor Everolimus

Background: Primary aldosteronism, characterized by inappropriately high and relatively autonomous aldosterone production, is one of the most frequent causes of secondary hypertension. In most cases, primary aldosteronism results from unilateral or bilateral adrenal hyperplasia and aldosterone-produ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Trinh, Beckey, Hepprich, Matthias, Betz, Matthias, Burkard, Thilo, Cavelti.Weder, Claudia, Seelig, Eleonora, Meienberg, Fabian, Kratschmar, Denise, Odermatt, Alex, Michael, Hall, Donath, Marc, Swierczynska, Marta
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2019
Matèries:
Cardiovascular Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551712/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-059
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars